Clinical Trials on Late Onset Neonatal Sepsis in Korea, Republic of
Total 12 results
-
Inha University HospitalCompletedHypotension | Oliguria | Infant, Premature | Necrotizing Enterocolitis of Newborn | Sepsis Newborn | Hypoperfusion in NewbornKorea, Republic of
-
NICHD Global Network for Women's and Children's...Boston University; University of Colorado, Denver; University of Alabama at Birmingham and other collaboratorsActive, not recruitingMaternal Death | Maternal Infections Affecting Fetus or Newborn | Neonatal SEPSIS | Maternal Sepsis During Labor | Neonatal Death | Postpartum SepsisZambia, Bangladesh, Congo, The Democratic Republic of the, Guatemala, India, Kenya, Pakistan
-
Hormozgan University of Medical SciencesCompletedNeonatal SepsisIran, Islamic Republic of
-
Columbia UniversityNational Institute on Aging (NIA)Recruiting
-
Murdoch Childrens Research InstituteKarolinska Institutet; University of Ibadan; Makerere University; Clinton Health... and other collaboratorsRecruitingPneumonia | Sepsis | Hypoxemia | Morality | Neonatal DiseaseCambodia, Lao People's Democratic Republic, Liberia, Nigeria, Rwanda, Uganda
-
BioMarin PharmaceuticalTerminatedLate-onset Pompe Patients Untreated or Treated With rhGAASpain, Slovenia, Serbia, Korea, Republic of, Greece, Australia, Singapore, Brazil, Canada, Taiwan, Ireland, Poland, Romania
-
Amicus TherapeuticsActive, not recruitingPompe Disease (Late-onset)United States, Germany, Taiwan, Belgium, Australia, Slovenia, Spain, Netherlands, Hungary, Japan, Austria, United Kingdom, France, Argentina, Canada, Sweden, Denmark, New Zealand, Greece, Korea, Republic of, Bosnia and Herzegovina, Ita... and more
-
Amicus TherapeuticsCompletedPompe Disease (Late-onset)United States, Australia, Korea, Republic of, Japan, Taiwan, Belgium, Slovenia, New Zealand, United Kingdom, France, Argentina, Canada, Spain, Bosnia and Herzegovina, Germany, Sweden, Hungary, Austria, Bulgaria, Denmark, Greece, I... and more
-
Genzyme, a Sanofi CompanyCompletedPompe Disease (Late-onset) | Glycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Glycogenosis 2United States, France, Netherlands
-
Genzyme, a Sanofi CompanyCompletedGlycogen Storage Disease Type II (GSD-II) | Pompe Disease (Late-Onset) | Glycogenesis Type II | Acid Maltase Deficiency (AMD)United States, France, Canada, Netherlands, Australia
-
Genzyme, a Sanofi CompanyApproved for marketingGlycogen Storage Disease Type II (GSD-II) | Acid Maltase Deficiency Disease | Glycogenosis 2 | Pompe Disease (Late-Onset)United States
-
Daniel BenjaminEunice Kennedy Shriver National Institute of Child Health and Human Development... and other collaboratorsCompletedHeart Failure | Epilepsy | Pain | Pneumonia | Sepsis | Inflammation | Hypertension | Chronic Kidney Diseases | Hemophilia | Schizophrenia | Central Nervous System Infections | Nosocomial Pneumonia | Insomnia | Anxiety | Bipolar Disorder | Neutropenia | Staphylococcal Infections | Bradycardia | Seizures | Urinary Tract Infections | Pulmonary... and other conditionsUnited States, Canada, United Kingdom, Israel, Singapore